Diagnostic Value of F-18-FDG PET/CT in Patients with Carcinoma of Unknown Primary

Cengiz A., Goksel S., Yurekli Y.

MOLECULAR IMAGING AND RADIONUCLIDE THERAPY, vol.27, no.3, pp.126-132, 2018 (ESCI) identifier identifier

  • Publication Type: Article / Article
  • Volume: 27 Issue: 3
  • Publication Date: 2018
  • Doi Number: 10.4274/mirt.64426
  • Journal Name: MOLECULAR IMAGING AND RADIONUCLIDE THERAPY
  • Journal Indexes: Emerging Sources Citation Index (ESCI), Scopus, TR DİZİN (ULAKBİM)
  • Page Numbers: pp.126-132
  • Keywords: Fluorodeoxyglucose, positron emission tomography/computed tomography, metastasis, unknown primary neoplasms, POSITRON-EMISSION-TOMOGRAPHY, PRIMARY TUMORS, PRIMARY SITE, COMPUTED-TOMOGRAPHY, CLINICAL-VALUE, PRIMARY CUP, FDG-PET/CT, METASTASES, CANCER, F-18-FLUORODEOXYGLUCOSE
  • Recep Tayyip Erdoğan University Affiliated: No

Abstract

Objective: The aim of this study is to investigate the clinical role of F-18-fluorodeoxyglucose (F-18-FDG) positron emission tomography/computed tomography (PET/CT) in patients with carcinoma of unknown primary (CUP).